Here are relevant reports on : global-live-streaming-industry
-
Top 10 Analytics Technologies – by Technology (Analytics-As-A-Service, Streaming Analytics, Edge Analytics, Data Lakes, Social Media Analytics, Predictive Analytics, Security Analytics, High-Performance Data Analytics, Content Analytics, and Video Analytics)
The top 10 analytics technologies market is expected to grow at a significant rate during the forecast period. The growth of this market is propelled by the advent of IoT and proliferation of massive amounts of data through connected devices, increasing focus on competitive insights, need for increased business agility and scalability, and growing volume and variety of business data across industry verticals. This report categorizes the top 10 analytics technologies market on the basis of software, service, data type, business function, application, industry vertical, and region.
- Published: February 2017
- Price: $ 4950
- TOC Available:
-
China IoT Market by Hardware (Processor, Memory, Logic, Sensor, & Connectivity), Software (Real-Time Streaming, Network Security, Data Management, Remote Monitoring, & Bandwidth Management), Platform, Service, and Application - Global Forecast to 2022
The China IoT market is expected to have a high growth potential till 2022. The total market is expected to reach USD 121.45 Billion by 2022 from USD 11.00 Billion in 2015, at a CAGR of 41.1% between 2016 and 2022. The major driving factors for the growth of the China IoT market are the growing demand for smartphones and other connecting devices, increasing internet penetration, rising trends of industrial automation, and mainstream adoption of cloud computing.
- Published: July 2016
- Price: $ 4950
- TOC Available:
-
IoT Device Management Market by Solution (Real-Time Streaming Analysis, Security Solutions, Data Management, Remote Monitoring, Network Bandwidth Management), Service, Application Area, Deployment Model, and Organization Size - Global Forecast to 2022
The IoT device management market size is expected to grow from USD 693.4 Million in 2017 to USD 2,559.6 Million by 2022, at a CAGR of 29.8% from 2017 to 2022. The growing penetration of heterogeneous smart devices and IoT sensors, mandates the critical need for reliable IoT device management platforms or solutions for device remote activation and provisioning, configuration and control, and its management. Converged device management platform offers a single platform to manage devices across multitude of domains and protocols for communication. IoT devices include heterogeneous stand-alone internet connected devices that need to be monitored and controlled from a remote location.
- Published: May 2017
- Price: $ 4950
- TOC Available:
-
Live Cell Encapsulation Market by Technique (Dripping (Simple, Electrostatic), Coaxial Airflow, Liquid Jet), Polymer (Alginate, Chitosan, Silica, Cellulose Sulfate), Application (Probiotics, Transplant, Drug Delivery, Research) - Forecast to 2024
The live cell encapsulation market is projected to grow to USD 303 million by 2024 from USD 250 million in 2018, at a CAGR of 3.2% during the forecast period. Growth in the live cell encapsulation market is primarily driven by factors such as the increasing public-private investments to support product development, increasing research to establish the clinical efficacy of cell encapsulation technologies, and rising public awareness related to the clinical role of encapsulated cells in disease management. BioTime, Inc. (US), Viacyte, Inc. (US), and Living Cell Technologies Ltd. (Australia) were the top three players in the live cell encapsulation market. Other prominent players operating in this market include Sigilon Therapeutics, Inc. (US), Evonik Industries (Germany), BÜCHI Labortechnik AG (Germany), Blacktrace Holdings Ltd (UK), and Sernova Corporation (Canada), among others. Furthermore, the key players in the developmental pipeline products in this market include Neurotech Pharmaceuticals, Inc. (US), Gloriana Therapeutics (US), Kadimastem (Israel), Beta-O2 Technologies, Inc. (Israel), Defymed (France), and Altucell, Inc. (US), among others.
- Published: April 2019
- Price: $ 4950
- TOC Available:
-
Europe Vaccines Market by Technology (Conjugate, Recombinant, Inactivated, Live Attenuated, Viral Vector, mRNA), Type (Monovalent, Multivalent), Disease (Pneumococcal, Flu, Hepatitis, MMR, RSV), Route of Administration (IM, SC, Oral) - Forecast to 2030
The Europe vaccines market, valued at US$10.53 billion in 2024, stood at US$9.97 billion in 2025 and is projected to advance at a resilient CAGR of 6.6% from 2025 to 2030, culminating in a forecasted valuation of US$13.74 billion by the end of the period. The vaccines market is growing due to fast global developments and the commercialization of vaccines, rising rates of infectious diseases, which require preventive measures, and government initiatives to encourage vaccinations, immunization programs, advancements, and investments in new vaccines against various diseases.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Microscope Camera Market by Type (Color, Monochrome), Sensor (CMOS, CCD), Resolution (SD, HD, UHD), Application (Live Cell Imaging, Pathology, Pharmaceutical & Biopharmaceutical Research), End User (Hospitals, Diagnostic Labs) - Global Forecast to 2029
The global microscope camera market, valued at US$178 million in 2023, stood at US$191 million in 2024 and is projected to advance at a resilient CAGR of 7.8% from 2024 to 2029, culminating in a forecasted valuation of US$278 million by the end of the period. Growth in this market is mainly driven by factors such as the growing prevalence of chronic diseases and advancing technological aspects in microscope cameras. Growth opportunities in the Asia Pacific region are also expected to leverage a positive environment for players playing in the microscope camera market.
- Published: September 2024
- Price: $ 4950
- TOC Available:
-
Human Microbiome Drugs Market by Type (Live Biotherapeutic Products, Fecal Microbiota-derived Therapeutics), Disease (Gastrointestinal, Infectious), End User (Hospitals, Clinics, Long-term Care) - Global Forecast to 2031
The human microbiome drugs market, valued at US$0.09 billion in 2024, stood at US$0.35 billion in 2025 and is projected to advance at a resilient CAGR of 35.2% from 2025 to 2031, culminating in a forecasted valuation of US$2.13 billion by the end of the period. The human microbiome drugs market is growing, driven by the increasing clinical success of live biotherapeutic products, rising prevalence of chronic and recurrent diseases, and expanding therapeutic applications beyond gastrointestinal disorders into metabolic, immune, and neurological conditions.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Vaccines Market by Technology (Conjugate, Recombinant, Inactivated, Live Attenuated, Viral Vector, mRNA), Type (Monovalent, Multivalent), Disease (Pneumococcal, Flu, Hepatitis, MMR, RSV), Route of Administration (IM, SC, Oral)-Global Forecast to 2030
The global vaccines market, valued at US$59.52 billion in 2024, stood at US$50.46 billion in 2025 and is projected to advance at a resilient CAGR of 4.8% from 2025 to 2030, culminating in a forecasted valuation of US$63.66 billion by the end of the period.
- Published: September 2025
- Price: $ 4950
- TOC Available:
-
Veterinary Vaccines Market by Type (Porcine, Poultry, Livestock, Companion Animals), Technology (Live Attenuated, Inactivated, Toxoid), Route of Administration (Intramuscular, Subcutaneous, Oral), End User (Hospitals, Clinics) - Global Forecast to 2030
The global veterinary vaccines market, valued at US$10.94 billion in 2024, stood at US$11.63 billion in 2025 and is projected to advance at a resilient CAGR of 6.8% from 2025 to 2030, culminating in a forecasted valuation of US$16.15 billion by the end of the period. The continuous focus on developing novel and advanced vaccines, combined with the increasing application of these vaccines in emerging economies, is expected to drive market growth.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Military Simulation and Training Market by Application (Army, Aviation, Naval), Type (Live, Virtual, Constructive), Platform (Land, Maritime, Airborne), Solution, Environment (Synthetic, Gaming), Technology, and Region - Global Forecast
The Military Simulation and Training market size is projected to reach USD 12.2 billion by 2027, at a CAGR of 5.6% during the forecast period. This region is expected to lead the market from 2021 to 2026, owing to increased investments and the adoption of advanced military simulators for all the platforms by countries in this region. The presence of prominent manufacturers and integrators of these Military Simulation and Training, including Lockheed Martin (US), Northrop Grumman (US), L3Harris Technologies, Inc. (US), and Raytheon Technologies (US), is also expected drive the market in the region over the forecast period.
- Published: April 2022
- Price: $ 4950
- TOC Available:
Records 11 to 20 of 50
